Bulletin
Investor Alert

Annovis Bio Inc.

NYS: ANVS

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Annovis Bio Inc.

After Hours

ANVS
/zigman2/quotes/216213707/composite

$

13.94

Change

+0.34 +2.50%

Volume

Volume 133

Jun 9, 2023, 7:30 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/216213707/composite

Previous close

$ 13.83

$ 13.60

Change

-0.23 -1.66%

Day low

Day high

$13.26

$14.20

Open
Open: 14.20

52 week low

52 week high

$9.51

$23.91

Open

Market cap

$122.47M

Average volume

91,272

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-3.57

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/anvs

MarketWatch News on ANVS

  2. Annovis Bio stock price target cut to $70 from $150 at Maxim Group

    7:43 a.m. Oct. 8, 2021

    - Tomi Kilgore

  3. Analyst Raises Price Targets on 3 Smaller Alzheimer's Stocks

    11:50 a.m. July 7, 2021

    - Barron's Online

  4. Annovis Bio stock price target raised to $150 from $45 at Maxim Group

    8:30 a.m. July 7, 2021

    - Tomi Kilgore

  7. Annovis Bio stock price target raised to $45 from $12 at Maxim Group

    7:33 a.m. May 13, 2021

    - Tomi Kilgore

  8. Annovis Bio started at buy with $12 stock price target at Maxim Group

    7:57 a.m. June 18, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/anvs

Other News on ANVS

  1. 10-K: ANNOVIS BIO, INC.

    5:05 p.m. March 31, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  4. Annovis (ANVS) Gains on FDA Authorization for AD Study

    12:57 p.m. Oct. 7, 2022

    - Zacks.com

  6. 10-Q: ANNOVIS BIO, INC.

    11:46 a.m. Aug. 8, 2022

    - Edgar Online - (EDG = 10Q, 10K)

/news/pressrelease/company/us/anvs

Press Releases on ANVS

  13. Annovis Bio to Present at the 2022 ThinkEquity Investor Conference

    7:31 a.m. Oct. 20, 2022

    - PR Newswire - PRF

  18. Annovis Bio's CEO Maria Maccecchini Issues Letter to Stockholders

    7:30 a.m. Sept. 8, 2022

    - PR Newswire - PRF

  19. Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer

    4:00 p.m. Aug. 29, 2022

    - PR Newswire - PRF

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.